Review Lymphotropic Viruses EBV, KSHV and HTLV in Latin America: Epidemiology and Associated Malignancies. A Literature-Based Study by the RIAL-CYTED Paola Chabay 1, Daniela Lens 2, Rocio Hassan 3, Socorro María Rodríguez Pinilla 4, Fabiola Valvert Gamboa 5, Iris Rivera 6, Fuad Huamán Garaicoa 7, Stella Maris Ranuncolo 8, Carlos Barrionuevo 9, Abigail Morales Sánchez 10, Vanesa Scholl 11, Elena De Matteo 1, Ma. Victoria Preciado 1 and Ezequiel M. Fuentes-Pananá 10,* 1 Multidisciplinary Institute for Investigation in Pediatric Pathologies (IMIPP), CONICET-GCBA. Molecular Biology Laboratory, Pathology Division, Ricardo Gutiérrez Children’s Hospital, Buenos Aires C1425EFD, Argentina;
[email protected] (P.C.);
[email protected] (E.D.M.);
[email protected] (M.V.P.) 2 Flow Cytometry and Molecular Biology Laboratory, Departamento Básico de Medicina, Hospital de Clínicas/Facultad de Medicina, Universidad de la República, Montevideo CP 11600, Uruguay;
[email protected] 3 Oncovirology Laboratory, Bone Marrow Transplantation Center, National Cancer Institute “José Alencar Gomes da Silva” (INCA), Ministry of Health, Rio de Janeiro 20230-130, Brazil;
[email protected] 4 Department of Pathology, University Hospital, Fundación Jiménez Díaz, 28040 Madrid, Spain;
[email protected] 5 Department of Medical Oncology, Cancer Institute and National League against Cancer, Guatemala City 01011, Guatemala;
[email protected] 6 Department of Hematology, Salvadoran Institute of Social Security, Medical Surgical and Oncological Hospital (ISSS), San Salvador 1101, El Salvador;
[email protected] 7 Department of Pathology, National Cancer Institute—Society to Fight Cancer (ION-SOLCA), Santiago de Guayaquil Catholic University, Guayaquil 090615, Ecuador;
[email protected] 8 Cell Biology Department, Institute of Oncology “Angel H.